| Product Code: ETC6736458 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Sumit Sagar | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 China Antimicrobial Resistance Market Overview |
3.1 China Country Macro Economic Indicators |
3.2 China Antimicrobial Resistance Market Revenues & Volume, 2021 & 2031F |
3.3 China Antimicrobial Resistance Market - Industry Life Cycle |
3.4 China Antimicrobial Resistance Market - Porter's Five Forces |
3.5 China Antimicrobial Resistance Market Revenues & Volume Share, By Indication, 2021 & 2031F |
3.6 China Antimicrobial Resistance Market Revenues & Volume Share, By Drug Class, 2021 & 2031F |
3.7 China Antimicrobial Resistance Market Revenues & Volume Share, By Mechanism of Action, 2021 & 2031F |
3.8 China Antimicrobial Resistance Market Revenues & Volume Share, By Pathogen, 2021 & 2031F |
4 China Antimicrobial Resistance Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of infectious diseases in China |
4.2.2 Growth in healthcare infrastructure and facilities |
4.2.3 Rising awareness about the importance of antimicrobial stewardship |
4.3 Market Restraints |
4.3.1 Overuse and misuse of antibiotics leading to resistance |
4.3.2 Limited access to effective antibiotics in rural areas |
4.3.3 Lack of robust regulatory framework for antimicrobial use |
5 China Antimicrobial Resistance Market Trends |
6 China Antimicrobial Resistance Market, By Types |
6.1 China Antimicrobial Resistance Market, By Indication |
6.1.1 Overview and Analysis |
6.1.2 China Antimicrobial Resistance Market Revenues & Volume, By Indication, 2021- 2031F |
6.1.3 China Antimicrobial Resistance Market Revenues & Volume, By Complicated Urinary Tract Infections (cUTI), 2021- 2031F |
6.1.4 China Antimicrobial Resistance Market Revenues & Volume, By Blood stream infections, 2021- 2031F |
6.1.5 China Antimicrobial Resistance Market Revenues & Volume, By Acute bacterial skin and skin structure infections (ABSSSI), 2021- 2031F |
6.1.6 China Antimicrobial Resistance Market Revenues & Volume, By Hospital acquired bacterial pneumonia and ventilator acquired bacterial pneumonia (HABP and VABP), 2021- 2031F |
6.1.7 China Antimicrobial Resistance Market Revenues & Volume, By Community acquired pneumonia (CAP), 2021- 2031F |
6.1.8 China Antimicrobial Resistance Market Revenues & Volume, By Others, 2021- 2031F |
6.2 China Antimicrobial Resistance Market, By Drug Class |
6.2.1 Overview and Analysis |
6.2.2 China Antimicrobial Resistance Market Revenues & Volume, By Combination therapies, 2021- 2031F |
6.2.3 China Antimicrobial Resistance Market Revenues & Volume, By Tetracyclines, 2021- 2031F |
6.2.4 China Antimicrobial Resistance Market Revenues & Volume, By Cephalosporins, 2021- 2031F |
6.2.5 China Antimicrobial Resistance Market Revenues & Volume, By Glycopeptides and Lipoglycopeptides, 2021- 2031F |
6.2.6 China Antimicrobial Resistance Market Revenues & Volume, By Oxazolidinones, 2021- 2031F |
6.2.7 China Antimicrobial Resistance Market Revenues & Volume, By Others, 2021- 2031F |
6.3 China Antimicrobial Resistance Market, By Mechanism of Action |
6.3.1 Overview and Analysis |
6.3.2 China Antimicrobial Resistance Market Revenues & Volume, By Protein Synthesis Inhibitors, 2021- 2031F |
6.3.3 China Antimicrobial Resistance Market Revenues & Volume, By Cell Wall Synthesis Inhibitors, 2021- 2031F |
6.3.4 China Antimicrobial Resistance Market Revenues & Volume, By Others, 2021- 2031F |
6.4 China Antimicrobial Resistance Market, By Pathogen |
6.4.1 Overview and Analysis |
6.4.2 China Antimicrobial Resistance Market Revenues & Volume, By Klebsiella pneumoniae, 2021- 2031F |
6.4.3 China Antimicrobial Resistance Market Revenues & Volume, By Pseudomonas aeruginosa, 2021- 2031F |
6.4.4 China Antimicrobial Resistance Market Revenues & Volume, By Staphylococcus aureus, 2021- 2031F |
6.4.5 China Antimicrobial Resistance Market Revenues & Volume, By Enterococcus Spp, 2021- 2031F |
6.4.6 China Antimicrobial Resistance Market Revenues & Volume, By Escherichia coli, 2021- 2031F |
6.4.7 China Antimicrobial Resistance Market Revenues & Volume, By Others, 2021- 2031F |
7 China Antimicrobial Resistance Market Import-Export Trade Statistics |
7.1 China Antimicrobial Resistance Market Export to Major Countries |
7.2 China Antimicrobial Resistance Market Imports from Major Countries |
8 China Antimicrobial Resistance Market Key Performance Indicators |
8.1 Percentage of hospitals implementing antimicrobial stewardship programs |
8.2 Number of new antibiotics approved by Chinese regulatory authorities |
8.3 Rate of adherence to antimicrobial prescribing guidelines by healthcare professionals |
9 China Antimicrobial Resistance Market - Opportunity Assessment |
9.1 China Antimicrobial Resistance Market Opportunity Assessment, By Indication, 2021 & 2031F |
9.2 China Antimicrobial Resistance Market Opportunity Assessment, By Drug Class, 2021 & 2031F |
9.3 China Antimicrobial Resistance Market Opportunity Assessment, By Mechanism of Action, 2021 & 2031F |
9.4 China Antimicrobial Resistance Market Opportunity Assessment, By Pathogen, 2021 & 2031F |
10 China Antimicrobial Resistance Market - Competitive Landscape |
10.1 China Antimicrobial Resistance Market Revenue Share, By Companies, 2024 |
10.2 China Antimicrobial Resistance Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here